Also trades as: 603127.SS (SHH) · $vol 296M
6127.HK HKSE
Joinn Laboratories(China)Co.,Ltd.
1W: +11.7%
1M: +32.3%
3M: +54.4%
YTD: +33.5%
1Y: +23.9%
3Y: +59.9%
5Y: -41.8%
HK$30.34 ($3.87)
-0.08 (-0.26%)
Weekly Expected Move ±10.8%
HK$24
HK$27
HK$30
HK$34
HK$37
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$339M
-45.6% ▼
5Y CAGR: +18.0%
Capital Expenditures
$269M
-39.8% ▼
5Y CAGR: +16.3%
Free Cash Flow
$70M
-83.8% ▼
5Y CAGR: +26.7%
Dividends Paid
$120M
+44.2% ▲
Buybacks
$108M
+5.0% ▲
Net Change in Cash
-$1.9B
-4021.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $314M | $556M | $1.1B | $392M | $70M |
| Depreciation & Amort. | $61M | $96M | $121M | $130M | $130M |
| Stock-Based Comp. | $30M | $24M | $10M | $6M | $0 |
| Change in Working Capital | $86M | $159M | $182M | $148M | $7M |
| Other Non-Cash Items | -$757K | $22M | -$415M | -$52M | $132M |
| Operating Cash Flow | $428M | $686M | $971M | $623M | $339M |
| — Investing Activities — | |||||
| Capital Expenditures | -$149M | -$237M | -$275M | -$193M | -$269M |
| Acquisitions (Net) | $186K | $0 | -$1.7B | -$90M | $0 |
| Investment Purchases | -$444M | -$2.6B | -$1.1B | -$647M | -$5.1B |
| Investment Sales | $342M | $789M | $907M | $606M | $3.4B |
| Other Investing | -$4M | $247K | -$13M | $8M | $10M |
| Investing Cash Flow | -$255M | -$2.1B | -$2.2B | -$315M | -$2.0B |
| — Financing Activities — | |||||
| Net Debt Issuance | $4M | -$4M | -$29M | -$7M | -$29M |
| Stock Repurchased | $0 | -$655K | -$24M | -$114M | -$108M |
| Dividends Paid | -$56M | -$95M | -$138M | -$214M | -$120M |
| Other Financing | $15M | $5.4B | $91M | -$140M | -$9M |
| Financing Cash Flow | -$37M | $5.3B | -$99M | -$362M | -$266M |
| Net Change in Cash | $128M | $3.8B | -$1.3B | -$46M | -$1.9B |
| Cash End of Period | $305M | $4.2B | $2.9B | $2.9B | $965M |
| Free Cash Flow | $279M | $448M | $696M | $430M | $70M |